Kura Oncology, Inc.

1. 01

   Fell 23.0% on 4 Nov 2026

   The 4 Nov 2026 decline of 23.0% was 8.6× its average daily move of 2.7% over the past year, and its largest one-day decline since 21 Nov 2024.

   Daily closes, split-adjusted · as of 4 Nov 2026

2. 02

   Behind SPY and its sector fund XLV over 1 year

   1 month: −27.7% (SPY −1.6%, XLV +13.5%). 3 months: −17.3% (SPY −0.4%, XLV +15.5%). 1 year: −23.6% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: KURA, SPY and XLV · as of 4 Nov 2026

3. 03

   Below its 50- and 200-day averages

   The 4 Nov 2026 close of $7.61 was 30.4% below its 50-day average ($10.94) and 22.4% below its 200-day average ($9.81). It has closed below the 200-day for 1 session, since 4 Nov 2026. The 50-day average crossed above the 200-day on 22 Jun 2026, 95 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   3.4% above its 52-week low

   Closed at $7.61 on 4 Nov 2026: 45.3% below the 52-week high of $13.90 (25 Aug 2026) and 3.4% above the low of $7.36 (5 Feb 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

5. 05

   Volume 4.9× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 8.2M shares was 4.9× the average of the 30 sessions before it (1.7M), as the price fell 23.0%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

At the 4 Nov 2026 close